人類健康新聞 | HIPRA

who we are

人類健康新聞

HIPRA launches a clinical trial to study its Covid-19 vaccine as 4th dose

09-11-2022

人類

covid vaccine

HIPRA creates a committee of experts for the Covid-19 vaccine project

13-07-2022

人類

企業

comité expertos

HIPRA starts a Phase III clinical trial of the Covid-19 vaccine with immunocompromised participants

13-06-2022

人類

Ensayo vacuna HIPRA

EMA starts rolling review of Covid-19 HIPRA’s vaccine

29-03-2022

人類

European Medicines Agency

GoodGut and Vall d'Hebron are studying the implementation of the first non-invasive diagnostic test to detect Irritable Bowel Syndrome

27-03-2022

人類

goodgut news

AEMPS authorizes phase III clinical trial of the HIPRA’s vaccine against Covid-19

25-03-2022

人類

Phase III